James Enlou Tcheng

In addition to my clinical responsibilities as an interventional cardiologist, my research interests include the study of antithrombotic therapies in cardiovascular disease, clinical informatics, artificial intelligence, and information technology systems. 

I have conducted and participated in numerous clinical trials, including the EPIC, PROLOG, EPILOG, EPISTENT, IMPACT, IMPACT II, TOTAL, PRIDE, ESPRIT, MEND-1, ELECT, and SUPPORT Trials.

My areas of expertise are an outgrowth of my clinical research, and includes use of the new antiplatelet therapeutics in the treatment of coronary artery disease; treatment of unstable angina and acute myocardial infarction; quality assurance and quality improvement; application of informatics and information technology to the delivery of care; and the application of excimer laser coronary angioplasty in the treatment of coronary artery disease.

My current focus is in clinical informatics, including initiatives spanning professional societies, regulatory and other government agencies, industry, and non-governmental organizations to develop clinical data standards, interoperability solutions, and to integrate structured reporting into clinical workflows. This includes harmonizing the clinical definitions of cardiovascular concepts across academia, regulatory agencies, the life sciences industry, professional societies, and standards organizations, to improve the capture, communication, interoperability, and analysis of healthcare information.

Key words: angioplasty, excimer laser, platelet glycoproteins, computers, clinical trials, clinical informatics.